A carregar...
P01.139 Safety and adverse event profile of tumor treating fields use in the EMEA region - a real-world data analysis
BACKGROUND: Tumor Treating Fields (TTFields) is approved for the treatment of newly diagnosed and recurrent glioblastoma. The efficacy and safety of TTFields in newly diagnosed GBM was previously demonstrated in the EF-14 phase 3 trial (n=695). Optune + temozolomide significantly improved survival o...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144089/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.181 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|